December 13, 2024 New Vaccine Prevents Severe RSV Illness A recent study showed the new vaccine was more than 90% effective in the prevention of hospitalizations and emergency department visits due to RSV among those 60 years old or older. Conexiant
December 13, 2024 Billions Carry Herpes, Study Reveals Two-thirds of the global population carry HSV, with distinct patterns of oral and genital infections across regions and age groups. Conexiant
December 12, 2024 Trump, RFK Jr. Eye Vaccine Policies Trump plans to discuss vaccine programs with RFK Jr., citing potential risks and the autism rate as key concerns. Reuters
December 12, 2024 54 Novel Drugs Await FDA Review An analysis published in the American Journal of Health-System Pharmacy provides an overview of the potential next wave of pharmaceuticals. Conexiant
December 10, 2024 USPSTF Issues Draft Cervical Cancer Guidelines For the first time, the Task Force has endorsed self-collected HPV testing. Conexiant
December 09, 2024 Do SGLT2i, GLP-1 RAs Cut Pneumonia, Sepsis Risk? In the largest real-world study to date, GLP-1 receptor agonists reduced pneumonia risk by 40% in type 2 diabetes patients. Conexiant